BamSEC and AlphaSense Join Forces
Learn More

TScan Therapeutics Inc. – Indentures

NASDAQ: TCRX    
Share price (5/22/26): $1.06    
Market cap (5/22/26): $69.3 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-3 40 pages TScan Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 39 pages TScan Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 11 pages TScan Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 11 pages Tscan Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.5
from S-3 40 pages Tscan Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 39 pages Tscan Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 11 pages Tscan Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.5
from S-3 41 pages Tscan Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 39 pages Tscan Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.4
from 10-K 5 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.4
from S-1 7 pages Amended and Restated Nominating Agreement
12/34/56
EX-4.3
from S-1 18 pages Registration Rights Agreement
12/34/56
EX-4.2
from S-1 53 pages Amended and Restated Investors’ Rights Agreement
12/34/56